Savara Pharmaceuticals

CFFT Has Provided $1.7m Research Award to US-based Savara Pharmaceuticals
Oct 21, 2013
Cystic Fibrosis Foundation Therapeutics (CFFT), an affiliate of the CF Foundation, has provided $1.7m research award to US-based Savara Pharmaceuticals for advancing the development of AeroVanc (vancomycin hydrochloride inhalation powder). ...

Tags: Savara Pharmaceuticals, Aerovanc Development
Aptalis Announced Co-Sponsorship of Controlled Release Society's Young Investigator Award
Nov 29, 2012
Aptalis Pharmaceutical Technologies, a business unit of Aptalis Pharma, has announced its co-sponsorship of Controlled Release Society's Young Investigator Award and its participation in the thirty-ninth Annual Meeting & Exposition of the ...

Tags: Aptalis pharmaceutical, professor Berkland, colloids, polymers
FDA Granted Orphan Drug Designation to Savara Pharmaceuticals'first Inhaled Antibiotic
Nov 28, 2012
The US Food and Drug Administration(FDA)has granted orphan drug designation to Savara Pharmaceuticals'first inhaled antibiotic,designed for the treatment of pulmonary methicillin-resistant Staphylococcus aureus(MRSA)infection in cystic ...

Tags: Orphan Drug, Savara Pharma, FDA, inhaled antibiotic, MRSA